Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder with a low survival rate. Pulmonary fibrosis is one of the complications of COVID-19 and has a high prevalence in COVID-19 patients. Currently, no effective therapies other than lung transplantation are available to cure IPF and post-COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lingyue, Su, Yafei, Hsia, Isaac, Xu, Ying, Vincent-Chong, Vui King, Mojica, Wilfrido, Seshadri, Mukund, Zhao, Ruogang, Wu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972768/
https://www.ncbi.nlm.nih.gov/pubmed/36919116
http://dx.doi.org/10.1016/j.omtn.2023.02.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972768/
https://www.ncbi.nlm.nih.gov/pubmed/36919116
http://dx.doi.org/10.1016/j.omtn.2023.02.031

Ejemplares similares